Related Experiment Video
Updated: Apr 27, 2026

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
Published on: October 3, 2025
Functional genomics and target gene validation in experimental and human disease
Johannes H Schulte1, Julika Pitsch2, Albert J Becker2
1University Children's Hospital of Essen, Hufelandstr. 55, 45122 Essen, Germany.
Common complex diseases involve multiple gene expression changes. Integrating human data with animal models via data mining helps identify disease-causing genes and develop new treatments for these multifactorial disorders.
Area of Science:
- Genetics and Molecular Biology
- Disease Pathogenesis
- Translational Medicine
Background:
- Frequent multifactorial diseases, unlike rare monogenic disorders, involve complex genetic interactions and multiple gene expression alterations.
- Understanding the genetic basis of common diseases like neuronal disorders and neoplasms is crucial for developing effective therapies.
- Current approaches often focus on single genes, necessitating new strategies for complex, polygenic conditions.
Purpose of the Study:
- To explore the integration of data mining with human disease tissue and animal model information.
- To identify and validate key genes involved in the pathogenesis of multifactorial diseases.
- To establish a framework for developing novel treatment pathways for common complex disorders.
Main Methods:
- Utilizing data mining techniques to integrate information from human disease tissues.
- Employing animal models for functional validation of candidate genes identified through data analysis.
- Comparative analysis of gene expression patterns in disease states versus healthy controls.
Main Results:
- Data mining successfully identified a multitude of genes with altered expression in multifactorial diseases.
- Functional validation in animal models confirmed the pathogenetic significance of several key target genes.
- The integrated approach enhanced the understanding of complex disease mechanisms.
Conclusions:
- Integrating human disease data with animal model studies via data mining is a powerful strategy.
- This approach increases the pathogenetic significance of identified target genes for common disorders.
- Functional validation in animal models is essential for advancing new treatment development for complex diseases.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
In-vitro Mutagenesis
Genomics
Pharmacogenetics and Pharmacogenomics: Overview
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...

